INSULET CORPORATION Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
INSULET CORPORATION (PODD) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of -$2.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-05
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-03-31 was -$1.90M, a 150.00% decline year-over-year.
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-03-31 was $3.80M.
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-03-31 was -$2.50M.
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-03-31 was -$100.00K.
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $11.50M.
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$6.80M, a 477.78% decline from fiscal 2023.
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $1.80M.
- INSULET CORPORATION effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2022 was -$4.30M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month as first filed | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$2.40M 10-Q · filed 2026-08-05 | ||||
| 2026-03-31 | -$1.90M 10-Q · filed 2026-05-06 | ||||
| 2025-12-31 | $11.50M 10-K · filed 2026-02-18 | ||||
| 2025-09-30 | $10.80M 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | $12.70M 10-Q · filed 2026-08-05 | ||||
| 2025-03-31 | $3.80M 10-Q · filed 2026-05-06 | ||||
| 2024-12-31 | -$6.80M 10-K · filed 2026-02-18 | ||||
| 2024-09-30 | $1.30M 10-Q · filed 2025-11-06 | $1.20M 10-Q · filed 2024-11-08 | |||
| 2024-06-30 | -$3.40M 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | -$2.50M 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | $1.80M 10-K · filed 2026-02-18 | ||||
| 2023-09-30 | -$1.20M 10-Q · filed 2024-11-08 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | ||||
| 2023-03-31 | -$100.00K 10-Q · filed 2024-05-10 | ||||
| 2022-12-31 | -$4.30M 10-K · filed 2025-02-21 | ||||
| 2022-09-30 | -$9.10M 10-Q · filed 2023-11-03 | ||||
| 2022-06-30 | -$3.50M 10-Q · filed 2023-08-09 | ||||
| 2022-03-31 | -$600.00K 10-Q · filed 2023-05-05 | ||||
| 2021-12-31 | -$5.50M 10-K · filed 2024-02-23 | ||||
| 2021-09-30 | -$3.90M 10-Q · filed 2022-11-04 | ||||
| 2021-06-30 | -$1.70M 10-Q · filed 2022-08-05 | ||||
| 2021-03-31 | -$300.00K 10-Q · filed 2022-05-06 | ||||
| 2020-12-31 | $4.80M 10-K · filed 2023-02-24 | ||||
| 2019-12-31 | $1.50M 10-K · filed 2022-02-24 | ||||
| 2018-12-31 | -$1.40M 10-K · filed 2021-02-24 | ||||
| 2017-12-31 | $400.00K 10-K · filed 2020-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |